Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: A prospective analysis

British Journal of Cancer

Volumn 73, Issue 4, 1996, Pages 531-538

  Janot, F ^a   Klijanienko, J ^a   Russo, A ^a   Mamet, J P ^a   De Braud, F ^a   El Naggar, A K ^b   Pignon, J P ^a   Luboinski, B ^a   Cvitkovic, E ^a,c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

Grading; Head and neck cancer; Metastatic risk; Ploidy; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; KERATIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL DIFFERENTIATION; FEMALE; FLUOROMETRY; HEAD CANCER; HUMAN; HUMAN TISSUE; KERATINIZATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MITOSIS INDEX; MULTIVARIATE ANALYSIS; NECK CANCER; PATHOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION;

EID: 0030038184     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.92     Document Type: Article

References (34)

1. ANNEROTH G, HANSEN LS AND SILVERMAN S. (1986). Malignancy grading in oral squamous cell carcinoma. Squamous cell carcinoma of the tongue and floor of the mouth: histologic grading in the clinical evaluation. J. Oral Pathol., 15, 162-168.
2. BAISCH H, GOLDE W AND LINDEN WA. (1975). Analysis of PCP data to determine the fraction of cells in various phases of the cell cycle. Radiat. Environ. Biophys., 12, 31-39.
3. BARONA DE GUZMAN R, MARTORELL MA, BASTERRA J, ARMENGOT M, ALVAREZ-VALDES R AND GARIN L. (1993). Prognostic value of histopathological parameter in 51 supraglottic squamous cell carcinomas. Laryngoscope, 103, 538-540.
4. BEGG AC, HOFLAND I, MOONEN L, BARTELINK H, SCHRAUB S, BONTEMPS P, LE FUR R, VAN DEN BOGAERT W, CASPERS R, VAN GLABBELSE M AND HORIAT JC. (1990). The predictive value of cell kinetic measurement in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int. J. Radiat. Oncol. Biol. Phys., 19, 1449-1453.
5. BRADFORD CR, POORE J, WILSON M, CAREY TE, MCCLATCHEY KD AND WOLF GT. (1994). Biological markers which predict response to chemotherapy in head and neck cancer. In Biology, Prevention and Treatment of Head and Neck Cancer. HN 149 Head & Neck, 16, 509.
6. BRODERS AC. (1920). Squamous cell epithelioma of the lip. JAMA, 74, 656-664.
7. CACHIN Y AND ESCHWEGE F. (1975). Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat. Rev., 2, 177-191.
8. COOLSE LD, COOKS TG, FORSTER G, JANES AS AND STELL PM. (1994). Prospective evaluation of cell kinetics in head and neck squamous carcinoma: The relationship to tumor factors and survival. Br. J. Cancer, 69, 717-720.
9. COX DR. (1972). Regression models and life tables. J. R. Stat. Soc., 34, 187-220.
10. CRISSMAN JD, LIN WY, GLUCKMAN JL AND CUMMINGS G. (1984). Prognostic value and histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer, 54, 2995-3001.
11. CRISSMAN JD, PAJALS IF, ZARBO RJ, MARCIAL VA AND AL-SARRAF M. (1987). Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinomas of the head and neck. Cancer, 99, 1391-1397.
12. DE BRAUD F, RUSSO A, KLIJANIENKO J, JANOT F, LIPINSKI M, TURSZ T, GANDIA D, MICHEAU C, PIGNON JM, GENTILE A, ARMAND JP AND CVITKOVIC E. (1991). Cytofluorometric ploidy in head and neck squamous cell carcinoma. Proc. Am. Assoc. Cancer Res., 32, 164.
13. ENSLEY JF, KISH JA, WEAVER AA, JACOBS JR, HASSAN M, CUMMINGS G AND AL-SARRAF M. (1988). The correlation of specific variables of tumor differentiation with response rate and survival in patients with advanced head and neck cancer treated with induction chemotherapy. Cancer, 63, 1487-1492.
14. ENSLEY JF AND MACIOROWSKI Z. (1994). Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck. Semin. Oncol., 21, 330-339.
15. ENSLEY J, CRISSMAN J, KISH J, JACOBS J, WEAVER A, KINZIE J, CUMMINGS G AND AL-SARRAF M. (1986). The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin-containing combination chemotherapy. Cancer, 57, 711-717.
16. ENSLEY JF, MACIOROWSKI Z AND PIETRASZKIRWICZ H. (1987). Tumor preparation for clinical application of flow cytometry. Cytometry, 8, 488-493.
17. GASPARINI G, WEIDNER N, MALUTA S, PAZZA F, BORRACHI P, MEZZETTI M, TESTOLIN A AND BEVILACQUA P. (1993). Intratumoral microvessel density and p53 protein correlation with metastasis in head and neck squamous cell carcinoma. Int. J. Cancer, 55, 739-744.
18. GREGG CM, BEALS TE, MCCLATCHY KM, FISHER SG AND WOLF GT. (1993). DNA content and tumor response to induction chemotherapy in patients with advanced laryngeal squamous cell carcinoma. Otolaryngeal Head Neck Surg., 108, 731-737.
19. JACOBSSON P, ENEROTH CM, KILLANDER D. MOBERGER G AND MARTENSSON B. (1973). Histological classification and grading of malignancy in carcinoma of the larynx. Acta Radiol. Ther. Phys. Biol., 12, 1-8.
20. KAPLAN EL AND MEIER P. (1958). Non parametric estimations from incomplete observations. J. Am. Stat. Assoc., 53, 457-481.
21. KLIJANIENKO J, MICHEAU C, CARLU C AND CAILLAUD JM. (1989). Significance of keratin 13 and 6 expression in normal, dysplastic and malignant squamous epithelium of pyriform fossa. Virchows Arch. A Pathol. Anal., 416, 121-124.
22. KLIJANIENKO J, EL-NAGGAR A, DE BRAUD F, MICHEAU C, JANOT F, LUBOINSKI B, GENTILE A, RUSSO A AND CVITKOVIC E. (1993). Keratins 6, 13 and 19 differential expression in squamous cell carcinoma of the head and neck. Anal. Quant. Cytol. Histol., 15, 335-340.
23. KLIJANIENKO J, EL-NAGGAR AK, DE BRAUD F, RODRIGUEZ-PERALTO JL, RODRIGUEZ R, ITZHAKI M, RUSSO A, JANOT F, LUBOINSKI B AND CVITKOVIC E. (1995). Tumor vascularisation, mitotic index, histopathologic grading and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer, 75, 1649-1656.
24. MANTEL N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50, 163-170.
25. MERKEL DE AND MCGUIRE WL. (1990). Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer, 65, 1194-1205.
26. NAKASHIMA T, MAEHARA Y, KOHNOE S, HAYASHI I AND KATSUTA Y. (1990). Histologie differentiation and chemosensitivity of human head and neck squamous cell carcinomas. Head Neck, 12, 406-410.
27. ROLAND NJ, CASLIN AW, NASH J AND STELL PM. (1992). Value of grading squamous cell carcinoma of the head and neck. Head Neck, 14, 224-229.
28. TUBIANA M. (1993). Kinetics of tumor cell proliferation. In Handbook of Chemotherapy in Clinical Oncology. Cvitkovic E, Droz JP, Armand JP, Khoury S (eds) 2nd ed pp. 23-35. Scientific Communication International: Paris.
29. VAN DER VELDEN LA, SCHAAFSMA HE, MANNI JJ, RAMAEKERS FC AND KUIJPERS W. (1993). Cytokeratin expression in normal and (pre) malignant head and neck epithelia: an overview. Head Neck, 15, 133-146.
30. VAN HOEF MEHM, KNOX WF, DHESI SS, HOWELL A AND SCHOR AM. (1993). Assessment of tumor vascularity as a prognastic factor in lymph node negative invasive breast cancer. Eur. J. Cancer, 29A, 1141-1145.
31. WALTER MA, PETERS GE AND PEIPER SC. (1991). Predicting radioresistance in early glottic squamous cell carcinoma by DNA content. Ann. Othorhinolaryngol., 100, 523-526.
32. WEIDNER N, SEMPLE JP, WELCH WR AND KOLKMAN J. (1991). Tumor angiogenesis. Correlation in invasive breast carcinoma. N. Engl. J. Med., 324, 1-8.
33. WORLD HEALTH ORGANIZATION (1978). Histological typing of upper respiratory tract tumors. In International Histological Classification of Tumors, no. 19, Shanmugaratnam K and Sobin LH (eds) p. 14. WHO: Geneva.
34. ZATTERSTROM UK, WENNERBERG J, EWERS SB, WILLEN R AND ATTEWELL R. (1991). Prognostic factors in head and neck cancer. Histologic grading, DNA ploidy, and nodal status. Head Neck, 13, 477-487.